Linkedin-in Envelope
Back to all News

New External, International Funding Opportunity

Dear Hood Alumni and Institutional Partners: Chiesi Pharmaceuticals is currently accepting research proposals for Respiratory and Neonatology therapeutic targets from academic medical centers, universities, & research institutions in North America and Europe. See https://www.chiesi.com/en/global-corporate-development/academic-rfp/ for more information.

Share:

more insights

Cami Martin, MD, MS, Chief Scientific Officer of the Charles Hood Foundation

The Charles H. Hood Foundation Welcomes Dr. Camilia Martin as Chief Scientific Officer

February 23, 2026

The Charles H. Hood Foundation is delighted to announce that Camilia (“Cami”) R. Martin, MD, MS, has joined the Foundation as Chief Scientific Officer. In this leadership role, Dr. Martin will steward and advance the Hood Foundation’s child health research portfolio, overseeing pediatric research awards and serving as a strategic scientific partner across initiatives, including the Hood Pediatric Innovation Hub.

Read more >